Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
1992-4-21
|
pubmed:abstractText |
The roles of diabetes mellitus, insulin-like growth factor I and insulin in vascular smooth muscle proliferation in vivo were studied. Proliferation was induced by endothelial injury (balloon catheterization) of rat aorta, and was measured as 3H-thymidine incorporation into DNA. Levels of insulin-like growth factor I mRNA and insulin-like growth factor I receptor mRNA were measured with a solution hybridization assay. The increase in DNA synthesis was most pronounced 2 days after injury in both normal and diabetic rats and declined thereafter, but DNA synthesis in aortas from diabetic rats was lower throughout the time period studied. Levels of insulin-like growth factor I mRNA and the receptor mRNA were both increased in balloon catheterized aortas, and time-course studies showed an increase in receptor mRNA prior to the increase in insulin-like growth factor I mRNA. Diabetic rats were treated with equimolar concentrations of insulin (35 nmol/day) or insulin-like growth factor I (31 nmol/day) for 5 days. Insulin-like growth factor I increased DNA synthesis in injured aortas 2 days after injury without improving blood glucose, whereas the effect of insulin was associated with a decrease in blood glucose levels. In conclusion, vascular smooth muscle proliferation is impaired by diabetes and stimulated by insulin treatment. Insulin-like growth factor I infusion stimulates vascular smooth muscle proliferation without affecting blood glucose, and gene expressions of insulin-like growth factor I and its receptor are increased in proliferating vascular smooth muscle, indicating that insulin-like growth factor I and involved in vascular smooth muscle proliferation in vivo.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Insulin,
http://linkedlifedata.com/resource/pubmed/chemical/Insulin-Like Growth Factor I,
http://linkedlifedata.com/resource/pubmed/chemical/RNA, Messenger,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Cell Surface,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Somatomedin,
http://linkedlifedata.com/resource/pubmed/chemical/Recombinant Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Thymidine,
http://linkedlifedata.com/resource/pubmed/chemical/insulin, neutral
|
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0012-186X
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
35
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
104-8
|
pubmed:dateRevised |
2011-11-17
|
pubmed:meshHeading |
pubmed-meshheading:1312491-Animals,
pubmed-meshheading:1312491-Aorta,
pubmed-meshheading:1312491-Body Weight,
pubmed-meshheading:1312491-DNA Replication,
pubmed-meshheading:1312491-Diabetes Mellitus, Experimental,
pubmed-meshheading:1312491-Endothelium, Vascular,
pubmed-meshheading:1312491-Insulin,
pubmed-meshheading:1312491-Insulin-Like Growth Factor I,
pubmed-meshheading:1312491-Kinetics,
pubmed-meshheading:1312491-Male,
pubmed-meshheading:1312491-Muscle, Smooth, Vascular,
pubmed-meshheading:1312491-RNA, Messenger,
pubmed-meshheading:1312491-Rats,
pubmed-meshheading:1312491-Rats, Inbred Strains,
pubmed-meshheading:1312491-Receptors, Cell Surface,
pubmed-meshheading:1312491-Receptors, Somatomedin,
pubmed-meshheading:1312491-Recombinant Proteins,
pubmed-meshheading:1312491-Thymidine
|
pubmed:year |
1992
|
pubmed:articleTitle |
In vivo proliferation of rat vascular smooth muscle in relation to diabetes mellitus insulin-like growth factor I and insulin.
|
pubmed:affiliation |
Department of Pharmacology, Linköping University, Faculty of Health Sciences, Sweden.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|